Lv2
156 积分 2021-08-10 加入
The Myocyte Enhancer Factor 2C (MEF2C) Is a Direct Transcriptional Target of HOXA9 and Mediates Leukemia Survival in Human Mixed-Lineage Leukemias
17小时前
求助中
Myocyte enhancer factor 2C in hematopoiesis and leukemia
7天前
已完结
Structural basis of tolvaptan binding to the vasopressin V2 receptor
10天前
已完结
Discovery of a Potent, Highly Selective, and In Vivo Anti-inflammatory Efficacious, P2Y6R Antagonist with a Novel Quinoline-pyrazole Scaffold
12天前
已完结
Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms
13天前
已完结
Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study
17天前
已完结
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
17天前
已完结
FGF amplification an important targeted for head and neck cancer patient? A case report of a patient with FGF amplification treated with erdafitinib
17天前
已完结
Targeting fibroblast growth factor receptor (FGFR) with inhibitors in head and neck cancers: Their roles, mechanisms and challenges
17天前
已完结
Discovery of Novel ERα and Aromatase Dual-Targeting PROTAC Degraders to Overcome Endocrine-Resistant Breast Cancer
26天前
已完结
皖公网安备34019202002308
